Erratum: Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Mei Kong,Zhaoming Wang,Xiaodong Teng,Liming Xu,Jimin Liu,Chenyang Jiang,Lisong Teng

2019-01-01

Abstract:[This corrects the article on p. 1674 in vol. 11, PMID: 31938268.].

What problem does this paper attempt to address?

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Mei Kong,Zhaoming Wang,Xiaodong Teng,Liming Xu,Jimin Liu,Chaozhe Jiang,Lisong Teng

2018-01-01

Abstract:Although indolent T-lymphoblastic proliferation (iT-LBP) in the extrathymic location have been shown to be a distinct clinicopathologic entity, carcinoma composed iT-LBP are rare. We retrospectively analyzed the clinicopathological features of 7 hepatic carcinoma cases with iT-LBP. There were 5 male and 2 female patients, aged from 37-54 (mean 47) years. All patients had a clinical history of chronic hepatitis B viral infection with high serum AFP level. Microscopically, these carcinomas were characterized by admixed with increased amounts of fibrous and small lymphocytes composed of regressive germinal centers. Immunohistochemically, in lymphoid tissues, some TDT+ cells were highlighted in the CD3+ area. These lymphoblasts localized predominantly between the cords of the carcinoma and interfollicular regions, diffused or only focal presented more than 50 TdT+ lymphoblasts/HPF. No EBV infection cells and T-cell antigen clonal rearrangement was detected. 3/4 cirrhotic patients developed HCC recurrence, while the 4-y survival rate was 100% in non-cirrhosis patients. It-LBP is a rare unusual proliferation and easily be misdiagnosed in HC patients. It does not seem to be associated with a specific HCC type. If HC companied with numerous small lymphocytes infiltration and showed high Ki67 index, a primary HC with iT-LBP should be considered in the lists of diagnosis.
Erratum: Evaluation of the clinicopathologic features of diffuse large B cell lymphoma after CD19-targeted CAR T-cell therapy emphasizing the potential diagnostic pitfalls.

Jun Zhou,Wenjing Zhang,Yanping Zhang,Saifang Zheng,Luting Zhou,Xiaoqun Yang,Chaofu Wang

2022-01-01

American journal of translational research

Abstract:[This corrects the article on p. 6751 in vol. 12, PMID: 33194070.].
Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.

Xiwei Ding,Yiyang Zhang,Tianlu Huang,Guifang Xu,Chunyan Peng,Gang Chen,Bo Kong,Helmut Friess,Shanshan Shen,Ying Lv,Lewis R Roberts,Lei Wang,Xiaoping Zou

2023-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 546 in vol. 9, PMID: 30949409.].
Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Lanlan Xiao,Xingqi Xu,Kaizhou Huang,Yalei Zhao,Lingjian Zhang,Lanjuan Li

DOI: https://doi.org/10.1155/2021/9875940

2021-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2019/3757149.].
Corrigendum: In vivo total or partial hepatectomy followed by ex vivo liver resection and autotransplantation for malignant tumors: a single center experience

Shaoyan Xu,Chenlu Hu,Zedong Jiang,Guogang Li,Bo Zhou,Zhenzhen Gao,Weilin Wang,Sheng Yan

DOI: https://doi.org/10.3389/fonc.2023.1251636

IF: 4.7

2023-08-11

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1214451.].

oncology
Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity

Hao Zheng,Wen-juan Zheng,Zhen-guang Wang,Yuan-ping Tao,Zhi-ping Huang,Le Yang,Liu Ouyang,Zhi-qing Duan,Yi-nuo Zhang,Bo-ning Chen,Dai-min Xiang,Gang Jin,Lu Fang,Fan Zhou,Bo Liang

DOI: https://doi.org/10.3389/fimmu.2022.1093403

IF: 7.3

2022-12-08

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.845193.].

immunology
Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

DOI: https://doi.org/10.1182/blood-2016-06-725010

IF: 20.3

2016-08-18

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2015-04-639203.].
EPHB4 Regulates the Proliferation and Metastasis of Oral Squamous Cell Carcinoma through the HMGB1/NF-κB Signalling Pathway: Erratum

Chen Yi,Xiliu Zhang,Hongyu Li,Guanhui Chen,Binghui Zeng,Yiming Li,Chao Wang,Yi He,Xun Chen,Zixian Huang,Dongsheng Yu

DOI: https://doi.org/10.7150/jca.87278

IF: 3.9

2023-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.59331.].

oncology
Erratum: PD-L1 expression in colon cancer and its relationship with clinical prognosis.

Tao Shan,Shuo Chen,Tao Wu,Yi Yang,Shunle Li,Xi Chen

2022-01-01

Abstract:[This corrects the article on p. 1764 in vol. 12, PMID: 31933995.].
Corrigendum to "MR Features Based on LI-RADS Identify Cytokeratin 19 Status of Hepatocellular Carcinomas" [eur. J. Radiol. 113 (2019) 7-14].

Xueqin Hu,Wentao Wang,Li Yang,Zhaoxia Yang,He‐Yue Liang,Ying Ding,Yuan Ji,Mengsu Zeng,Sheng‐Xiang Rao

DOI: https://doi.org/10.1016/j.ejrad.2019.03.013

IF: 4.531

2019-01-01

European Journal of Radiology

Abstract:The authors regret . The authors would like to apologise for any inconvenience caused. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomasEuropean Journal of RadiologyVol. 113PreviewLiver cancer is the second most frequent cause of cancer death worldwide [1,2]. A total of 70%–90% primary liver cancers occurring are hepatocellular carcinoma (HCC) in the world and recently HCC is increasing in incidence in many countries [2,3]. Most often, HCC represents a multistep process on a background of chronic hepatitis or cirrhosis [4–6]. Full-Text PDF
Erratum: Accelerated Liver Fibrosis in Hepatitis B Virus Transgenic Mice: Involvement of Natural Killer T Cells

Zixue Jin,Rui Sun,Wei H,Xiang Gao,Yongyan Chen,Zhigang Tian

DOI: https://doi.org/10.1002/hep.24135

IF: 17.298

2011-01-01

Hepatology

Abstract:In the January 2011 issue of HEPATOLOGY, in the article entitled “Accelerated Liver Fibrosis in Hepatitis B Virus Transgenic Mice: Involvement of Natural Killer T Cells” (HEPATOLOGY 201153:219–229), the unit of the y axis in Fig. 7A should have been 105, and Fig. 8C (left panel) was inadvertently substituted for Fig. 8B; the corrections do not change the conclusions or the results. The corrected versions of Figs. 7A and 8B are provided here.
Erratum: Approaching hemophagocytic lymphohistiocytosis

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1369687

IF: 7.3

2024-01-22

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1210041.].

immunology
Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Sen Miao,Gaoda Ju,Chonghua Jiang,Bing Xue,Lihua Zhao,Rui Zhang,Han Diao,Xingzhou Yu,Linlin Zhang,Xiaozao Pan,Hua Zhang,Lijuan Zang,Lei Wang,Tianhao Zhou

DOI: https://doi.org/10.3389/fmed.2024.1375203

IF: 3.9

2024-02-05

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1167676.].

medicine, general & internal
Correction: Corrigendum: Patient-specific Hepatocyte-Like Cells Derived from Induced Pluripotent Stem Cells Model Pazopanib-Mediated Hepatotoxicity

Yukti Choudhury,Yi‐Chin Toh,Jiangwa Xing,Yinghua Qu,Jonathan Poh,Huan Li,Hui Shan Tan,Ravindran Kanesvaran,Hanry Yu,Min‐Han Tan

DOI: https://doi.org/10.1038/srep46391

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Scientific Reports 7: Article number: 41238; published online: 25 January 2017; updated: 25 April 2017 The original version of this Article contained an error in the spelling of the author Huan Li, which was incorrectly given as Li Huan. The Author Contributions Statement, Study concept and design: Y.
Corrigendum to “Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma” [Genes Dis 6(4) 2019 407–418]

Junling Tang,Li Zhang,Tiejun Zhou,Zhiwei Sun,Liangsheng Kong,Li Jing,Hongyun Xing,Hongyan Wu,Yongli Liu,Shixia Zhou,Jingyuan Li,Mei Chen,Fang Xu,Jirui Tang,Tao Ma,Min Hu,Dan Liu,Jing Guo,Xiaofeng Zhu,Yan Chen,Ting Ye,Jianyu Wang,Xiaoming Li,H. Rosie Xing

DOI: https://doi.org/10.1016/j.gendis.2021.06.001

2022-01-01

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2018.12.002.].

genetics & heredity,biochemistry & molecular biology
Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report

Wen Han,Bei Wang,Xiang Yong,Yi Zhang,Mingyu Shao,Chun Wang

DOI: https://doi.org/10.3389/pore.2023.1611151

2023-05-12

Abstract:Objective: Indolent T-lymphoblastic proliferation (iT-LBP) is a non-neoplastic disease with an indolent clinical course, manifesting as hyperplasia of immature extrathymic T-lymphoblastic cells. Isolated iT-LBP has been observed, but the majority of iT-LBP cases has been seen in conjunction with other diseases. iT-LBP is easily misdiagnosed as T-lymphoblastic lymphoma/leukemia, and understanding the disease of indolent T-lymphoblastic proliferation may prevent misdiagnosis and missed diagnosis in pathological diagnosis. Case presentation: We report a case morphology, immunophenotypic, and molecular features of iT-LBP combined with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma and review relevant literature. Conclusion: iT-LBP combined with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma is relatively rare and should always be considered as a differential diagnosis of T-lymphoblastic lymphoma and scirrhous hepatocellular carcinoma as the two disorders show highly similar clinical features.

oncology,pathology
Correction: Zheng, L., et al. PBN11-8, a Cytotoxic Polypeptide Purified from Marine Bacillus, Suppresses Invasion and Migration of Human Hepatocellular Carcinoma Cells by Targeting Focal Adhesion Kinase Pathways. Polymers 2018, 10, 1043

Lanhong Zheng,Xiangjie Zhu,Kangli Yang,Meihong Zhu,Ammad Ahmad Farooqi,Daole Kang,Mi Sun,Yixin Xu,Xiukun Lin,Yingang Feng,Fangfang Liang,Fuming Zhang,Robert J. Linhardt,Ammad Farooqi,Robert Linhardt

DOI: https://doi.org/10.3390/polym13010166

IF: 5

2021-01-05

Polymers

Abstract:The authors wish to make a change to the published paper [...]

polymer science
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Xiaofan Hu,Mingyang Bao,Jiacheng Huang,Lin Zhou,Shusen Zheng

DOI: https://doi.org/10.3389/fonc.2020.617539

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:CORRECTION article Front. Oncol., 20 November 2020Sec. Molecular and Cellular Oncology Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.617539
Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Lei Qian,Nanya Wang,Huimin Tian,Haofan Jin,Hengjun Zhao,Chao Niu,Hua He,Tingwen Ge,Wei Han,Jifan Hu,Dan Li,Fujun Han,Jianting Xu,Xiao Ding,Jingtao Chen,Wei Li,Jiuwei Cui

DOI: https://doi.org/10.1155/2022/9761463

IF: 4.4929

2022-07-18

Journal of Immunology Research

Abstract:In the article titled "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients" [1], the authors wish to correct Figure 2. Due to an oversight when preparing the manuscript, it is duplicated with Figure 3 in a previous publication by the authors [2]. These two studies were related, and the data were saved to the same location, contributing to the erroneous selection of the image for publication. The authors apologise for this error and provide the corrected Figure 2 as follows:

immunology

Erratum: Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Erratum: Evaluation of the clinicopathologic features of diffuse large B cell lymphoma after CD19-targeted CAR T-cell therapy emphasizing the potential diagnostic pitfalls.

Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.

Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Corrigendum: In vivo total or partial hepatectomy followed by ex vivo liver resection and autotransplantation for malignant tumors: a single center experience

Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity

Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

EPHB4 Regulates the Proliferation and Metastasis of Oral Squamous Cell Carcinoma through the HMGB1/NF-κB Signalling Pathway: Erratum

Erratum: PD-L1 expression in colon cancer and its relationship with clinical prognosis.

Corrigendum to "MR Features Based on LI-RADS Identify Cytokeratin 19 Status of Hepatocellular Carcinomas" [eur. J. Radiol. 113 (2019) 7-14].

Erratum: Accelerated Liver Fibrosis in Hepatitis B Virus Transgenic Mice: Involvement of Natural Killer T Cells

Erratum: Approaching hemophagocytic lymphohistiocytosis

Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Correction: Corrigendum: Patient-specific Hepatocyte-Like Cells Derived from Induced Pluripotent Stem Cells Model Pazopanib-Mediated Hepatotoxicity

Corrigendum to “Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma” [Genes Dis 6(4) 2019 407–418]

Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report

Correction: Zheng, L., et al. PBN11-8, a Cytotoxic Polypeptide Purified from Marine Bacillus, Suppresses Invasion and Migration of Human Hepatocellular Carcinoma Cells by Targeting Focal Adhesion Kinase Pathways. Polymers 2018, 10, 1043

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"